← Back to Search

Twice per week dialysis for Kidney Failure (D-LITE Trial)

N/A
Recruiting
Research Sponsored by Queen's University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

D-LITE Trial Summary

This trial is designed to determine whether elderly patients who dialyze twice weekly have improved well-being compared to those who dialyze thrice-weekly. The primary outcomes will be metrics of feasibility and safety.

Eligible Conditions
  • Kidney Failure
  • Dialysis
  • Hemodialysis

D-LITE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Loss to trial completion
Percent of weekly post hemodialysis weights that are within 1 kg of prescribed dry weight
Percent of weekly potassium values falling within normal range.
+2 more
Secondary outcome measures
Change in Patient's Quality of Life - Using Edmonton Symptom Assessment System (ESAS-R)

D-LITE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Twice per week dialysisExperimental Treatment1 Intervention
Twice-weekly 4 hour dialysis treatment (Monday and Friday or Tuesday and Saturday).
Group II: Thrice per week dialysisActive Control1 Intervention
Standard thrice-weekly 4 hour dialysis treatment (Monday, Wednesday and Friday or Tuesday, Thursday and Staurday)

Find a Location

Who is running the clinical trial?

Queen's UniversityLead Sponsor
365 Previous Clinical Trials
120,377 Total Patients Enrolled
2 Trials studying Kidney Failure
429 Patients Enrolled for Kidney Failure

Media Library

Twice per week dialysis Clinical Trial Eligibility Overview. Trial Name: NCT03787719 — N/A
Kidney Failure Clinical Trial 2023: Twice per week dialysis Highlights & Side Effects. Trial Name: NCT03787719 — N/A
Kidney Failure Research Study Groups: Twice per week dialysis, Thrice per week dialysis
Twice per week dialysis 2023 Treatment Timeline for Medical Study. Trial Name: NCT03787719 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people are agreeing to participate in this test?

"That is correct, the trial information available on clinicaltrials.gov indicates that the study is currently recruiting patients. The original posting date was June 27th, 2018 and it was last updated on May 26th, 2022. They are looking for a total of 40 participants from 1 site."

Answered by AI

Are there any open positions for patients who want to enroll in this trial?

"The trial is still open for recruitment, as seen on the clinicaltrials.gov website. This particular study was first made available on 6/27/2018 and has had 5/26/2022 as its most recent update."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Dialysis-Less Frequently In The Elderly
Dr. Christine White 2018. "Dialysis-Less Frequently In The Elderly". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03787719.
All > Dialysis
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top